Obesity not a big factor in dosing of systemic cancer therapies: ASCO guidelines

Cancer patients should receive full weight-based dosing of chemotherapy regardless of their obesity status, according to an ASCO Guideline Update. A systematic review of the literature found there was little evidence for capping chemotherapy doses based on concerns about increased toxicity with full weight-based dosing in heavier people. Additionally, underdosing was more likely to be ...

Already a member?

Login to keep reading.

© 2022 the limbic